NSCLC Archive - Seite 2 von 9 - IOZK

Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1

2021-11-02/in Dendritic Cells, International Publications, NSCLC /von 2021-11-02 / Cancers (Basel) 2021 Nov;13(21)

Targeting CD166 lung cancer stem cells: Molecular study using murine dendritic cell vaccine

2021-08-23/in Dendritic Cells, International Publications, NSCLC, SCLC /von 2021-08-23 / Toxicol Appl Pharmacol 2021 Oct;429:115699

MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells

2021-04-21/in International Publications, Newcastle Disease Virus, NSCLC /von 2021-04-21 / Oncol Lett 2021 Jun;21(6):482

A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer

2020-03-17/in Hyperthermia, International Publications, NSCLC /von 2020-03-17 / J Adv Res 2020 Jul;24:175-182

Dendritic cell/cytokine-induced killer cell-based immunotherapy in lung cancer: What we know and future landscape

2019-06-21/in Dendritic Cells, International Publications, NSCLC /von 2019-06-21 / J. Cell. Physiol. 2020 Jan;235(1):74-86

Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial.

2019-06-02/in Dendritic Cells, International Publications, NSCLC /von 2019-06-02 / J Clin Oncol 37, 2019 (suppl; abstr 9039)

Neoantigen-based personalized DC vaccine for lung cancer: An update of translational study.

2019-05-31/in Dendritic Cells, NSCLC /von 2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e20674)

Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer

2019-04-20/in Hyperthermia, International Publications, NSCLC /von 2019-04-20 / Chin. Med. J. 2019 Apr;132(8):922-927

[Vaccines for the treatment of non-small cell lung cancer]

2019-03-20/in Dendritic Cells, International Publications, NSCLC /von 2019-03-20 / Rev Mal Respir 2019 Mar;36(3):415-425

Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients‘ preference-based study (PPPS)

2018-10-29/in Dendritic Cells, International Publications, NSCLC /von 2018-10-29 / Clin Transl Oncol 2019 Jun;21(6):721-728